4//SEC Filing
Zilkha Nathaniel M 4
Accession 0001209191-10-044277
CIK 0001232524other
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 6:37 PM ET
Size
8.3 KB
Accession
0001209191-10-044277
Insider Transaction Report
Form 4
Zilkha Nathaniel M
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2010-08-25+12,500→ 12,500 totalExercise: $8.23Exp: 2020-08-25→ Common Stock (12,500 underlying) - Award
Phantom Stock
2010-08-25$8.23/sh+2,131$17,538→ 12,861 total→ Common Stock (2,131 underlying)
Footnotes (3)
- [F1]Each share of phantom stock is the amount equivalent to one share of the Issuer's common stock.
- [F2]The shares of phantom stock become payable in common stock upon the earlier to occur of the tenth business day following (i) the Reporting Person's separation from service as a director or (ii) a Change of Control of the Issuer (as defined under the Issuer's Directors Deferred Compensation Plan, as amended).
- [F3]The option shares shall vest in a series of twelve (12) successive equal installments upon completion of each month of Continuous Service (as defined under the Issuer's 2007 Non-Employee Directors Stock Option Plan, as amended) over the one (1)-year period measured from August 15, 2010.
Documents
Issuer
JAZZ PHARMACEUTICALS INC
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001359315
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 6:37 PM ET
- Size
- 8.3 KB